Nightstar Therapeutics Plc (NITE) Return on Investment ROI from the first quarter of 2019 to first quarter of 2018 and for the year 2019, average high and low, overall ranking from Mar 31 2019 to Mar 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nightstar Therapeutics Plc  (NITE)


Nightstar Therapeutics Plc's ROI from its first quarter of 2019 to the first quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nightstar Therapeutics Plc's ROI in the first quarter of 2019?
Nightstar Therapeutics Plc recorded a cumulative net loss of $-39 million during 12 months ending in the first quarter of 2019, resulting in a negative return on investment (ROI) of -29.61%.

Within the Healthcare sector 395 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2018 from 0 to 3891.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter
Y / Y Investment Change TTM 4.39 % 29.66 % 76.6 % 260.66 % 5433.81 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 150 167 100 109 126
Return On Investment (TTM) -29.61 % -29.42 % -36.71 % -36.54 % -32.25 %
NITE's Overall Ranking # 3891 # 0 # 0 # 0 #
Seq. Investment Change TTM 4.83 % 8.85 % -5.37 % -3.33 % 30.21 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -39 -37 -42 -44 -41

NITE Company Profile >> Back to NITE Roi Comparisons >> See Annual NITE Return On Investment



Return On Investment NITE's Ranking
Within: No.
Industry # 38
Sector # 396
Overall # 3891

Return On Investment Statistics
High Average Low
-23.6 %
-39.14 %
-53.22 %
(Dec 31 2017)   (Dec 31 2018)







Financial Statements
Nightstar Therapeutics Plc's I. Quarter Investments $ 150 Millions NITE's Balance sheet
Nightstar Therapeutics Plc's I. Quarter Income $ -16 Millions Quarterly NITE's Income Statement
NITE's Income by Division See NITE's Income by Division


NITE Annual Return On Investment (Dec 31 2018)
2018		 (Dec 31 2017)
2017


Total Investments in Millions 166 126 0 0 0
Y / Y Investment Growth 31.94 % - - - -
Net Income in Millions -37 -30 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -22.2 % -23.59 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NITE's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NITE's Competitors
Subscribers only: Roi for Nightstar Therapeutics Plc's Suppliers
Subscribers only: Return On Investment for NITE's Customers

Other Ratios
NITE's Roa NITE's Inventory Turnover Ratio NITE's Growth Rates NITE's Dividend Statistics
NITE's Profitability Ratios NITE's Asset Turnover Ratio NITE's Dividend Growth
NITE's Roe NITE's Valuation Ratios NITE's Financial Strength Ratios NITE's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2019, within Healthcare Sector ROI

Date modified: 2026-09-08T21:14:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.